Steven Aslanides
Psychiatric/Mental Health · Fort Myers, FLNPI 1023530102
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Alkermes, Inc. at 26.0% of the total. Reporting peaked in 2023 at $221 and has fallen 82.8% since, to $38 in 2024. That places this record below the midpoint for psychiatric/mental health clinicians in FL, where the typical reported total is $664.
Across 21 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$104
- Johnson & Johnson$96
- Indivior Inc.$74
- Otsuka America Pharmaceutical, Inc.$48
- Lundbeck LLC$34
- Teva Pharmaceuticals USA, Inc.$17
- plus $28 from 2 others
What the payments were for
- Food & beverage$401100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 5 | $104 |
| Johnson & Johnson | 5 | $96 |
| Indivior Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Lundbeck LLC | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
How this compares
$401 in reported general payments places this provider in the 40th percentile of 3,096 psychiatric/mental health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyzine Hcl | 14 | $241 |
| Trazodone Hcl | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Fort Myers
- Dylan DemarsFort Myers$24K
- Jacqueline BannisterFort Myers$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.